vs
Side-by-side financial comparison of FONAR CORP (FONR) and GENCOR INDUSTRIES INC (GENC). Click either name above to swap in a different company.
FONAR CORP is the larger business by last-quarter revenue ($25.5M vs $23.6M, roughly 1.1× GENCOR INDUSTRIES INC). GENCOR INDUSTRIES INC runs the higher net margin — 14.6% vs 8.0%, a 6.6% gap on every dollar of revenue. On growth, FONAR CORP posted the faster year-over-year revenue change (2.4% vs -25.0%). GENCOR INDUSTRIES INC produced more free cash flow last quarter ($10.1M vs $-227.0K). Over the past eight quarters, FONAR CORP's revenue compounded faster (-0.3% CAGR vs -23.9%).
FONAR Corp is a specialized medical technology firm that designs, manufactures, and distributes innovative MRI systems including upright and open models. It primarily serves U.S. hospitals, diagnostic imaging centers, and healthcare providers, delivering high-precision scanning solutions for clinical diagnostic use.
Gencor Industries Inc is a leading manufacturer of heavy construction and infrastructure equipment, specializing in asphalt production plants, thermal combustion systems, and supporting road-building machinery. It primarily serves North American and global construction markets, supplying products to both public sector infrastructure projects and private commercial construction operators.
FONR vs GENC — Head-to-Head
Income Statement — Q2 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $25.5M | $23.6M |
| Net Profit | $2.1M | $3.4M |
| Gross Margin | — | 28.7% |
| Operating Margin | 13.5% | 13.2% |
| Net Margin | 8.0% | 14.6% |
| Revenue YoY | 2.4% | -25.0% |
| Net Profit YoY | 4.7% | -9.8% |
| EPS (diluted) | — | $0.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $25.5M | $23.6M | ||
| Q3 25 | $26.0M | $18.8M | ||
| Q2 25 | $27.3M | $27.0M | ||
| Q1 25 | $27.2M | $38.2M | ||
| Q4 24 | $24.9M | $31.4M | ||
| Q3 24 | $25.0M | $20.9M | ||
| Q2 24 | $25.9M | $25.6M | ||
| Q1 24 | $25.7M | $40.7M |
| Q4 25 | $2.1M | $3.4M | ||
| Q3 25 | $2.3M | $1.9M | ||
| Q2 25 | $729.3K | $3.8M | ||
| Q1 25 | $2.5M | $6.1M | ||
| Q4 24 | $2.0M | $3.8M | ||
| Q3 24 | $3.1M | $1.5M | ||
| Q2 24 | $830.4K | $2.6M | ||
| Q1 24 | $1.9M | $6.2M |
| Q4 25 | — | 28.7% | ||
| Q3 25 | — | 24.2% | ||
| Q2 25 | — | 26.5% | ||
| Q1 25 | — | 29.7% | ||
| Q4 24 | — | 27.6% | ||
| Q3 24 | — | 25.6% | ||
| Q2 24 | — | 23.9% | ||
| Q1 24 | — | 30.3% |
| Q4 25 | 13.5% | 13.2% | ||
| Q3 25 | 14.1% | -1.2% | ||
| Q2 25 | 5.3% | 11.6% | ||
| Q1 25 | 15.2% | 17.0% | ||
| Q4 24 | 11.9% | 14.7% | ||
| Q3 24 | 21.0% | 5.9% | ||
| Q2 24 | 7.4% | 7.8% | ||
| Q1 24 | 16.8% | 17.4% |
| Q4 25 | 8.0% | 14.6% | ||
| Q3 25 | 8.7% | 10.2% | ||
| Q2 25 | 2.7% | 14.2% | ||
| Q1 25 | 9.2% | 16.0% | ||
| Q4 24 | 7.9% | 12.1% | ||
| Q3 24 | 12.6% | 6.9% | ||
| Q2 24 | 3.2% | 10.0% | ||
| Q1 24 | 7.3% | 15.3% |
| Q4 25 | — | $0.23 | ||
| Q3 25 | — | $0.13 | ||
| Q2 25 | — | $0.26 | ||
| Q1 25 | — | $0.42 | ||
| Q4 24 | — | $0.26 | ||
| Q3 24 | — | $0.10 | ||
| Q2 24 | — | $0.17 | ||
| Q1 24 | — | $0.42 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $121.0K | $147.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $176.9M | $215.2M |
| Total Assets | $217.2M | $228.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $121.0K | $147.7M | ||
| Q3 25 | $122.0K | $136.3M | ||
| Q2 25 | $56.5M | $136.0M | ||
| Q1 25 | $123.0K | $143.7M | ||
| Q4 24 | $121.0K | $130.1M | ||
| Q3 24 | $136.0K | $115.4M | ||
| Q2 24 | $56.5M | $116.6M | ||
| Q1 24 | $134.0K | $117.1M |
| Q4 25 | — | — | ||
| Q3 25 | — | $0 | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $0 | ||
| Q2 24 | $66.9K | — | ||
| Q1 24 | — | — |
| Q4 25 | $176.9M | $215.2M | ||
| Q3 25 | $174.9M | $211.8M | ||
| Q2 25 | $172.6M | $209.9M | ||
| Q1 25 | $171.9M | $206.1M | ||
| Q4 24 | $169.8M | $200.0M | ||
| Q3 24 | $168.7M | $196.1M | ||
| Q2 24 | $166.0M | $194.7M | ||
| Q1 24 | $165.8M | $192.1M |
| Q4 25 | $217.2M | $228.9M | ||
| Q3 25 | $218.4M | $222.6M | ||
| Q2 25 | $216.9M | $220.2M | ||
| Q1 25 | $214.9M | $223.9M | ||
| Q4 24 | $208.0M | $218.2M | ||
| Q3 24 | $212.3M | $208.1M | ||
| Q2 24 | $214.2M | $201.8M | ||
| Q1 24 | $209.6M | $206.0M |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.00× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | 0.00× | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $171.0K | $11.1M |
| Free Cash FlowOCF − Capex | $-227.0K | $10.1M |
| FCF MarginFCF / Revenue | -0.9% | 43.0% |
| Capex IntensityCapex / Revenue | 1.6% | 4.1% |
| Cash ConversionOCF / Net Profit | 0.08× | 3.23× |
| TTM Free Cash FlowTrailing 4 quarters | $5.7M | $-3.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $171.0K | $11.1M | ||
| Q3 25 | $1.7M | $-275.0K | ||
| Q2 25 | $4.2M | $-23.9M | ||
| Q1 25 | $3.1M | $12.4M | ||
| Q4 24 | $2.2M | $14.8M | ||
| Q3 24 | $1.7M | $-3.2M | ||
| Q2 24 | $4.6M | $-1.0M | ||
| Q1 24 | $2.8M | $11.7M |
| Q4 25 | $-227.0K | $10.1M | ||
| Q3 25 | $-177.0K | $-1.3M | ||
| Q2 25 | $3.6M | $-24.4M | ||
| Q1 25 | $2.6M | $12.3M | ||
| Q4 24 | $1.5M | $14.5M | ||
| Q3 24 | $-148.0K | $-3.3M | ||
| Q2 24 | $4.2M | $-1.4M | ||
| Q1 24 | $2.6M | $11.7M |
| Q4 25 | -0.9% | 43.0% | ||
| Q3 25 | -0.7% | -6.8% | ||
| Q2 25 | 13.1% | -90.4% | ||
| Q1 25 | 9.4% | 32.2% | ||
| Q4 24 | 6.0% | 46.1% | ||
| Q3 24 | -0.6% | -15.8% | ||
| Q2 24 | 16.1% | -5.6% | ||
| Q1 24 | 10.2% | 28.7% |
| Q4 25 | 1.6% | 4.1% | ||
| Q3 25 | 7.2% | 5.4% | ||
| Q2 25 | 2.4% | 1.8% | ||
| Q1 25 | 2.2% | 0.4% | ||
| Q4 24 | 3.0% | 1.0% | ||
| Q3 24 | 7.2% | 0.4% | ||
| Q2 24 | 1.6% | 1.5% | ||
| Q1 24 | 0.7% | 0.0% |
| Q4 25 | 0.08× | 3.23× | ||
| Q3 25 | 0.75× | -0.14× | ||
| Q2 25 | 5.79× | -6.24× | ||
| Q1 25 | 1.26× | 2.04× | ||
| Q4 24 | 1.14× | 3.88× | ||
| Q3 24 | 0.53× | -2.22× | ||
| Q2 24 | 5.54× | -0.41× | ||
| Q1 24 | 1.50× | 1.87× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FONR
| Managementof Diagnostic Imaging Centers | $23.2M | 91% |
| Manufacturingand Servicingof Medical Equipment | $2.4M | 9% |
GENC
Segment breakdown not available.
